The same panel will meet Wednesday to consider tot-sized shots from Moderna and Pfizer for the littlest kids, those under 5.
FILE - A vial of the Moderna COVID-19 vaccine is displayed on a counter at a pharmacy in Portland, Ore. on Dec. 27, 2021. NEW YORK — A government advisory panel Tuesday endorsed a second brand of COVID-19 vaccine for school-age children and teens.
Moderna’s COVID-19 vaccine has long been available for adults in the U.S. and elsewhere and more than three dozen countries offer it to older children, too. If the FDA authorizes Moderna’s vaccine for teens and younger children, the Centers for Disease Control and Prevention will next decide whether to formally recommend the shots.
“I believe that this will provide families an important option” and may be particularly important for families who live in areas where coronavirus spread is increasing, said another panel member, Dr. Ofer Levy of Boston Children’s Hospital. “That clearly needs to be watched closely going forward as we expand the use of the vaccine,” said Dr. Mark Sawyer, a panel member from the University of California, San Diego’s medical school.
Vaccine effectiveness was estimated at 93% for the teens, and 77% for the younger children, according to the FDA analysis. However, the research was done when earlier versions of the coronavirus were causing most U.S. infections, before more contagious versions emerged. It’s also based on a limited number of COVID-19 cases, making the estimates a bit rough.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA advisers back Moderna's COVID-19 vaccine for older kidsA government advisory panel has endorsed a second brand of COVID-19 vaccine for school-age children and teens. The expert panel agreed Tuesday that the vaccine made by Moderna is safe and effective enough to give to U.S. kids ages 6 to 17.
Read more »
FDA Advisers Back Moderna's COVID-19 Vaccine for Older KidsA government advisory panel Tuesday endorsed a second brand of COVID-19 vaccine for school-age children and teens. The Food and Drug Administration’s outside experts voted unanimously that Moderna’s vaccine is safe and effective enough to give kids ages 6 to 17. If the FDA agrees, it would become the second option for those children, joining Pfizer’s vaccine. The same FDA…
Read more »
FDA advisers back Moderna's COVID-19 vaccine for older kidsA government advisory panel has endorsed a second brand of COVID-19 vaccine for school-age children and teens.
Read more »
FDA advisers back Moderna’s Covid vaccine for older kidsIf authorized by the FDA, it would be just the second Covid vaccine available to teens and schoolchildren in the U.S.
Read more »
FDA panel endorses Moderna's COVID vaccine for teens, school-age kidsAn FDA advisory panel endorsed on Tuesday Moderna's COVID-19 vaccine for teenagers and school-aged children.
Read more »